Carregant...

Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells

Fenfluramine is prescribed either alone or in combination with phentermine as part of Fen-Phen, an anti-obesity medication. Fenfluramine was withdrawn from the US market in 1997 due to reports of heart valvular disease, pulmonary arterial hypertension, and cardiac fibrosis. Particularly, idiopathic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yao, Weijuan, Mu, Wenbo, Zeifman, Amy, Lofti, Michelle, Remillard, Carmelle V., Makino, Ayako, Perkins, David L., Garcia, Joe G., Yuan, Jason X. J., Zhang, Wei
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3224433/
https://ncbi.nlm.nih.gov/pubmed/22140631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2045-8932.87310
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!